Longitudinal TNF Levels Mainly Stable With Adalimumab in RA

FRIDAY, Feb. 1, 2019 -- For patients with rheumatoid arthritis (RA), longitudinal tumor necrosis factor (TNF) concentrations are mainly stable during adalimumab treatment, although early low TNF is strongly linked to nonresponse to treatment,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news